Sherbrooke Park Advisers’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,397
Closed -$143K 521
2025
Q1
$143K Buy
22,397
+5,379
+32% +$51.9K 0.07% 470
2024
Q4
$202K Buy
+17,018
New +$290K 0.06% 586
2024
Q3
Sell
-22,876
Closed -$546K 907
2024
Q2
$546K Buy
+22,876
New +$537K 0.1% 368

Other funds holding ASPN

Sherbrooke Park Advisers's ASPN Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 22,397 shares — an estimated $143K sold.

Sherbrooke Park Advisers first reported a position in ASPN in Q2 2024 and held it in 3 quarters. The position peaked at $546K in Q2 2024. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 22,397 Aspen Aerogels shares in Q2 2025, an estimated $143K.
  • Sherbrooke Park Advisers first reported a position in Aspen Aerogels in Q2 2024 and held it in 3 quarters.
  • Sherbrooke Park Advisers's Aspen Aerogels position peaked at $546K in Q2 2024.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.